Science AI Journal
Medicine · Research topic

Open research questions in Berberine and alkaloids research

99 unresolved questions extracted from the limitations and future-work sections of 193 Berberine and alkaloids research papers in our library. Each links back to the study that raised it.

What the literature leaves open

  • The study identifies methodological limitations of the included studies, including inadequate reporting of randomization methods and allocation concealment. The study notes that the available preclinical evidence has not been systematically quantified, making it difficult to draw firm conclusions. The study highlights the need for more rigorous and standardized experimental designs to strengthen the evidence base and validate the therapeutic potential of sinomenine.

    Neuroprotective effects and mechanistic insights of sinomenine in ischemic stroke: a systematic review and meta-analysis of preclinical animal studies · 2026 · DOI

  • Methodological limitations of the included studies, - Inadequate reporting of important methodological details, - Lack of standardized experimental designs, - Small sample sizes, - Limited generalizability to human populations

    Neuroprotective effects and mechanistic insights of sinomenine in ischemic stroke: a systematic review and meta-analysis of preclinical animal studies · 2026 · DOI

  • The discovery and processing of plant-based medicinal products face numerous challenges, - Access restrictions, difficulties in material identification, and the conservation of wild species are challenges, - The precise mechanisms of action of berberine remain incompletely elucidated

    Pharmacological properties and therapeutic potential of berberine: a comprehensive review · 2025 · DOI

  • Further systematic investigation of berberine's mechanisms of action is needed, - Clinical implementation of berberine for various diseases should be explored, - The effects of berberine on different populations and diseases should be studied

    Pharmacological properties and therapeutic potential of berberine: a comprehensive review · 2025 · DOI

  • These findings support further investigation of plant secondary metabolites as potential adjuvants to anticancer therapy.

    Antiproliferative effects of berberine, corinan and curcumo-berberine on RPMI8226 multiple myeloma cells and their interaction with vincristine · 2026 · DOI

  • Importance: Berberine is a potential therapy for metabolic disorders, yet its effects on visceral adipose tissue (VAT) and liver fat remain uncertain.

    Berberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD · 2026 · DOI

  • However, the pharmacological mechanism of action of BBR in anti-chronic atrophic gastritis (CAG) remains unclear.

    Elucidation of the mechanism of berberine against gastric mucosa injury in a rat model with chronic atrophic gastritis based on a combined strategy of multi-omics and molecular biology · 2025 · DOI

  • However, its exact role in regulating autophagy and alleviating atherosclerotic inflammation remains unclear.

    Berberine alleviates atherosclerosis by modulating autophagy and inflammation through the RAGE-NF-κB pathway · 2025 · DOI

  • Most BIAs are derived and isolated from medicinal plants; however, these plants are predominantly wild resources that are scarce.

    Advances in the biosynthesis of naturally occurring benzylisoquinoline alkaloids · 2025 · DOI

  • Numerous transcription factors have been shown to be involved in vinblastine biosynthesis, while the function of SPL members (CrSPL) has not yet been investigated in C.

    Comprehensive analysis of SPL gene family and miR156a/SPLs in the regulation of terpenoid indole alkaloid biosynthesis in Catharanthus roseus L · 2025 · DOI

  • This combination warrants further exploration as a therapeutic strategy against resistant infections.

    The in vitro evaluation of synergistic effects of ciprofloxacin and berberine hydrochloride against Pseudomonas aeruginosa · 2025 · DOI

  • To date, no studies have examined the effects of berberine on acute hyperglycemia.

    Berberine ameliorates acute hyperglycemia and hypoinsulinemia induced by ketamine/xylazine in rats: role of alpha2 adrenergic receptors, oxidative stress and inflammatory suppressing mechanisms · 2025 · DOI

  • In comparison with its known pathway in Coptis species, its biosynthesis in Phellodendron species remains elusive.

    Convergent evolution of berberine biosynthesis · 2024 · DOI

  • Previous studies have demonstrated the beneficial therapeutic effect of berberine (BBR) on SCM; however, the underlying mechanisms of action remain unclear.

    Berberine ameliorates septic cardiomyopathy through protecting mitochondria and upregulating Notch1 signaling in cardiomyocytes · 2024 · DOI

  • However, the evolutionary mechanisms responsible for their chemo-diversity are not well understood.

    Lineage‐Specific CYP80 Expansion and Benzylisoquinoline Alkaloid Diversity in Early‐Diverging Eudicots · 2024 · DOI

  • However, the mechanisms by which BBR regulates the immunological microenvironment in HCC has not been fully elucidated.

    Berberine Protects against Hepatocellular Carcinoma Progression by Regulating Intrahepatic T Cell Heterogeneity · 2024 · DOI

  • Berberine, a natural isoquinoline alkaloid, has demonstrated broad-spectrum antimicrobial activity, though its antifungal potential and underlying mechanisms against both yeast-like and filamentous fungi are not fully understood.

    The Antifungal Effects of Berberine and Its Proposed Mechanism of Action Through CYP51 Inhibition, as Predicted by Molecular Docking and Binding Analysis · 2024 · DOI

  • The natural product, sanguinarine, displays remarkable anti-tumor properties by disturbing energy homeostasis; however, the underlying mechanism has not yet been elucidated.

    Sanguinarine Induces Necroptosis of HCC by Targeting PKM2 Mediated Energy Metabolism · 2024 · DOI

  • Although their anti-obesogenic and antidiabetic properties have been widely studied, comparative research on their impact on the gene expression of adipokines, such as resistin (Res), omentin (Ome), visfatin (Vis) and apelin (Ap), has not been reported.

    Comparative Effects of Gymnema sylvestre and Berberine on Adipokines, Body Composition, and Metabolic Parameters in Obese Patients: A Randomized Study · 2024 · DOI

  • The phytochemical composition and antidiabetic potential of Dactylicapnos scandens root tuber have not been fully explored. There is a need to identify novel antidiabetic therapeutics from plant sources.

    Phytochemical profiling and antidiabetic potential of Dactylicapnos scandens root tuber using LC-MS, GC-MS and molecular docking · 2026 · DOI

  • The complexity of the gut microbiota-glycerophospholipid metabolic axis. The need for effective methods to evaluate the skeletal benefits of Berberine. The challenge of translating the findings from animal models to human applications.

    Berberine Attenuates Glucocorticoid-Induced Bone Loss in Mice: Associated with the Gut Microbiota–Glycerophospholipid Metabolic Axis · 2026 · DOI

  • investigate the long-term effects of BBR on bone health, - investigate the effects of BBR on human subjects, - explore the potential of BBR as a therapeutic agent for glucocorticoid-induced osteoporosis

    Berberine Attenuates Glucocorticoid-Induced Bone Loss in Mice: Associated with the Gut Microbiota–Glycerophospholipid Metabolic Axis · 2026 · DOI

  • The lack of effective therapeutic agents for oral squamous cell carcinoma. The need for further studies on the anticancer potential of traditional Ayurvedic formulations.

    Integrative in vitro and in silico assessment of the anticancer activity of Berberis aristata formulation against oral squamous cell carcinoma · 2026 · DOI

  • Poor oral bioavailability due to berberine's permanent positive charge, limited membrane permeability, and extensive first-pass metabolism. The need for further pharmacokinetic optimization and clinical validation. The complexity of berberine's molecular mechanisms and the need for further research.

    Berberine and its structural diversity: structure–activity relationships, molecular mechanisms, and drug discovery opportunities · 2026 · DOI

  • The need for further pharmacokinetic optimization and clinical validation of berberine. The lack of understanding of berberine's molecular mechanisms and structure-activity relationships. The need for the development of berberine derivatives with improved pharmacokinetic properties.

    Berberine and its structural diversity: structure–activity relationships, molecular mechanisms, and drug discovery opportunities · 2026 · DOI

Most-cited papers in Berberine and alkaloids research

Most recent work

Find a gap in your own Berberine and alkaloids research sub-topic

This page shows what the Berberine and alkaloids research literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 4.5M-paper local library and writes the gaps from its rows.

Open the Research Gap Finder →

Related topics in Medicine

Artificial Intelligence in Healthcare and Education
2,404 open questions
Substance Abuse Treatment and Outcomes
2,046 open questions
Dementia and Cognitive Impairment Research
1,148 open questions
Smoking Behavior and Cessation
1,056 open questions
Innovations in Medical Education
1,015 open questions
Physical Activity and Health
1,010 open questions
Attention Deficit Hyperactivity Disorder
970 open questions
Schizophrenia research and treatment
962 open questions
99 open questions have been extracted from the limitations and future-work passages of 193 Berberine and alkaloids research papers in our 4.5M-paper local library. Each one below links back to the study that raised it, so you can read the original claim in context.

Tools for your next paper

Gaps & Literature SearchFind open questions in any field — 120,000+ open gaps mined from our own library.Pre-CheckIs your paper ready? A Tier 1–5 acceptance probability in seconds.Journal FinderA ranked shortlist of target journals from a 17,500-venue index.Duplicate Publication CheckerCheck prior-publication & salami-slicing risk across 8 sources.Citation GeneratorFreeA DOI or title → APA, MLA, Vancouver, Chicago, BibTeX, RIS. No signup.Graphical Abstract MakerFreeTurn your findings into a colorblind-safe graphical abstract.

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.